| Thanks to SoCalBio Weekly Update Sponsor |
Join us in June SoCalBio/Image 2000 Golf Classic
Title Sponsor
 Benefiting When: June 28, 2010Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
(SoCalBio)
enany@socalbio.org
| May 10, 2010  |
| Map of the Week | Who Won 510K Decisions During April 2010?
|
| Featured Story | SenoRx, Inc. Acquired by Bard for $212 Million
SenoRx, located in Irvine, California, markets the EnCor
stereotactic-guided and MRI-guided breast biopsy systems, the Gel Mark line of breast tissue markers and the Contura balloon catheter for the treatment of breast cancer, and had 2009 revenues of $55.6 million. Upon completion of the merger, the SenoRx organization will become part of Bard's Peripheral Vascular division... Read more
|
 |  |
| Upcoming SoCalBio Events | May 28, 7:00 to 9:30 AM
SoCalBio Networking Forum in Orange County
Navigating Healthcare ReformsUCI University Club in IrvineLearn from industry experts how the recently passed healthcare reform package can impact your business: from funding opportunities, changing reimbursement rules to the medical device tax. Click here to RSVPJune 10, 8:00 AM to 12:00 Noon
SoCalBio Open HouseWilshire Grand Hotel in Downtown Los Angeles Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.Click here to RSVPJune 28, 10:00 AM - 8:30 PM
SoCalBio/Image 2000 Golf Classic
(ending with with reception and dinner)Old Ranch Country Club in Seal BeachJoin your medtech and biotech colleagues and friends for a great day of golf in one of the exquisite courses in Southern California while you show your support for the bioscience industry, the Multiple Sclerosis Society and SoCalBio.Click here to play, buy a foursome, or secure a tee sign |
| Welcome New SoCalBio Member | Graves & Walton, LLP
(Los Angeles and Pasadena)
 Graves & Walton is an intellectual property litigation boutique founded to provide high-end intellectual property litigation services to companies and individuals. The firm represents plaintiffs and defendants in patent, trademark and unfair competition, copyright, and antitrust litigation... Click here to learn more
|
| |
| Trends | Bioscience Jobs Show Some Growth Despite Recession
The U.S. bioscience industry added 19,000 jobs in 2008, a 1.4 percent increase to bring the total to 1.42 million, a relative bright spot at a time when the private sector shed 0.7 percent of jobs and had entered into the first year of a deep and painful recession, according to a report from the nonprofit independent research and development firm Battelle and the Biotechnology Industry Association. What's more, The
Battelle/BIO State Bioscience Initiatives 2010 shows that publicly traded bioscience related companies on the whole generated positive net growth through 2009... Read More
|
| Analysis | Will Biosimilars Alter Biotech Landscape?
The pathway for follow-on biologics establishes a new dialogue between the FDA and manufacturers. It encourages different strategies for best-possible routes to market for follow-on, or
biosimilar, products, and even developing "bio-betters" .... Read more
|
| From the Lab Bench | Caltech Researchers Develop a Method to Connect Thousands of Neural Nanosensors to Each Other and to an Outside Controller
The Caltech team led by Akram Sadek describes a piezoelectric NEMS device that could be fabricated beneath every microelectrode to transduce the signal. In the core of the probe, a silicon waveguide could be engineered to transmit laser light generated externally and to transmit the reflected signals from each NEMS device, all along the same
waveguide. This could potentially increase the number of electrodes that can be packed from 100 to the tens of thousands, and could also reduce the cross-section of the probe, minimizing tissue damage. Such a system would be a highly important tool in neuroscience and for neuroprosthetics in medicine.... Read more
|
| Litigation | Watson Settles Patent Dispute with Teva
The company's subsidiary, Watson Laboratories, Inc. reached a settlement with Teva Women's Health, Inc. on outstanding patent litigation related to Teva's Seasonale
(levonorgestrel and ethinyl estradiol tablets
USP, 0.15 mg/0.03 mg) product.... Read more
Watson Confirms EVISTA Patent Challenge
Eli Lilly and Company filed suit against Watson on May 3, 2010 in the United States District Court for the Southern District of Indiana seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent Nos. 6,458,811, 6,797,719 and 6,894,064.... Read more
|
Personnel
| Response Genetics Appoints David O'Toole Chief Financial Officer
Mr. O'Toole brings to Response Genetics over 26 years of accounting, business and finance experience primarily focused on global companies and the life science and biotechnology industry. Mr. O'Toole was most recently CFO at Abraxis Biosciences, Inc., a publicly traded biotechnology company with a $2 billion market capitalization. Prior to
Abraxis, Mr. O'Toole was a partner at Deloitte & Touche
LLP, where he was responsible for managing services for many large and medium sized life science and biotechnology companies. Mr. O'Toole holds a Bachelor of Science degree in accounting from the University of Arizona.... Read more
Cameron Health Appoints Warren Watson to Executive Chairman of Board of Directors
Prior to joining the Cameron Health board, Mr. Watson spent seven years as the Vice President of Research and Development for Medtronic's Cardiac Rhythm Management business as well as leading Medtronic's Corporate R&D Council. Prior to that role, Warren served as general manager of multiple Medtronic businesses and was the first Vice President of Marketing for Medtronic's Tachyarrhythmia Business. Mr. Watson has served on seven corporate and nonprofit boards, including Endocardial Solutions,
Survivalink, and CardioMems... Read more
AVANIR Pharmaceuticals Announces Hiring of Michael McFadden as Vice President of U.S. Sales and Managed Markets
Mr. McFadden joins AVANIR with over 20 years of pharmaceutical commercialization experience. He most recently served in various leadership roles in sales and managed care at Amylin Pharmaceuticals. ... Read more
|
| Jobs Available | BioScreen Testing Services (Torrance)
BioScreen, a full service laboratory in industrial microbiology and analytical chemistry. is seeking to fill the following position:
NeoMend (Irvine) NeoMend, a wound-healing product company, is seeking to fill the following position: |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
